Your browser is no longer supported. Please, upgrade your browser.
Settings
PRGO Perrigo Company plc daily Stock Chart
PRGO [NYSE]
Perrigo Company plc
IndexS&P 500 P/E- EPS (ttm)-10.47 Insider Own0.47% Shs Outstand142.79M Perf Week-1.19%
Market Cap9.99B Forward P/E14.93 EPS next Y4.69 Insider Trans-0.31% Shs Float137.24M Perf Month-5.49%
Income-1502.50M PEG- EPS next Q1.81 Inst Own82.40% Short Float8.15% Perf Quarter-17.39%
Sales5.64B P/S1.77 EPS this Y-95.80% Inst Trans7.77% Short Ratio5.41 Perf Half Y-21.69%
Book/sh60.52 P/B1.16 EPS next Y-34.29% ROA- Target Price79.62 Perf Year-27.29%
Cash/sh2.55 P/C27.43 EPS next 5Y-1.48% ROE- 52W Range65.47 - 111.00 Perf YTD-15.96%
Dividend0.64 P/FCF- EPS past 5Y-59.80% ROI0.60% 52W High-36.98% Beta0.79
Dividend %0.91% Quick Ratio1.10 Sales past 5Y0.10% Gross Margin38.20% 52W Low6.84% ATR2.07
Employees13242 Current Ratio1.70 Sales Q/Q0.80% Oper. Margin- RSI (14)42.32 Volatility2.68% 2.53%
OptionableYes Debt/Eq0.68 EPS Q/Q- Profit Margin- Rel Volume0.83 Prev Close71.85
ShortableYes LT Debt/Eq0.65 EarningsMay 22 Payout- Avg Volume2.07M Price69.95
Recom2.80 SMA20-4.70% SMA50-0.54% SMA200-13.99% Volume1,719,759 Change-2.64%
Mar-03-17Reiterated B. Riley & Co. Neutral $83 → $67
Feb-28-17Reiterated Canaccord Genuity Buy $100 → $97
Feb-22-17Initiated Canaccord Genuity Buy $100
Jan-23-17Reiterated Jefferies Hold $84 → $70
Jan-17-17Reiterated RBC Capital Mkts Sector Perform $92 → $85
Nov-11-16Upgrade BofA/Merrill Underperform → Neutral
Nov-11-16Reiterated B. Riley & Co. Neutral $87 → $97
Aug-11-16Reiterated Barclays Overweight $120 → $110
Jul-22-16Upgrade Deutsche Bank Hold → Buy $115
Jun-20-16Downgrade Argus Buy → Hold
Apr-26-16Reiterated RBC Capital Mkts Sector Perform $140 → $109
Apr-26-16Reiterated Barclays Overweight $180 → $120
Apr-25-16Downgrade Wells Fargo Outperform → Market Perform
Apr-25-16Downgrade BofA/Merrill Buy → Underperform
Feb-22-16Downgrade Goldman Neutral → Sell
Feb-19-16Initiated Wells Fargo Outperform
Feb-19-16Downgrade B. Riley & Co. Buy → Neutral $239 → $146
Jan-21-16Initiated Barclays Overweight $180
Dec-10-15Upgrade Argus Hold → Buy $170
Dec-03-15Initiated Morgan Stanley Equal-Weight
May-26-17 04:45AM  Edited Transcript of PRGO earnings conference call or presentation 23-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-23-17 04:05PM  Perrigo, Taro Show Perils of Failure to Branch in Branded Drugs TheStreet.com
May-22-17 07:36PM  Perrigo reports 4Q loss Associated Press
06:28PM  Perrigo to Conduct Conference Call on May 23, 2017 at 8:30 AM ET PR Newswire
09:07AM  Incyte Was the S&P 500s Top Gainer on May 18 Market Realist
May-16-17 10:47AM  Billionaire Einhorn Trims Apple, Adds GM, Exits Yelp in Q1: 13F Filing Investopedia
May-11-17 08:41AM  Biotech And Pharma Industry And Stock News Investor's Business Daily
May-09-17 09:48AM  Perrigo Company (PRGO) Q1 Earnings: Disappointment in Store? Zacks
May-08-17 08:16AM  Perrigo Announces Two New Independent Directors PR Newswire
May-06-17 12:16PM  PERRIGO ALERT: J&W Investigates Perrigo for Price Fixing and Restatement of Financials Following CFO Resignation; Harmed Investors Encouraged to Contact Firm PR Newswire
May-04-17 08:23AM  Generic Drugmakers Tumble as Perrigo Discloses DoJ Search Zacks
May-03-17 06:10PM  Apple and Perrigo slip while Delphi and Straight Path climb Associated Press -5.09%
04:38PM  Generic Drugmakers Crash After Perrigo Searched In Antitrust Probe Investor's Business Daily
02:14PM  Generics Drop Across Board as DOJ Inquiry Expands TheStreet.com
12:56PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Perrigo Company plc Business Wire
12:07PM  PERRIGO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Perrigo Co. to Contact The Firm Business Wire
11:23AM  Perrigo Alert: J&W Investigates Perrigo Company plc after U.S. Department of Justice Issues Search Warrants; All Investors Encouraged to Contact Firm PR Newswire
08:53AM  Perrigo Stock Sliding on DOJ Search TheStreet.com
08:51AM  Perrigo Company plc Announces Quarterly Dividend PR Newswire
07:54AM  Early movers: AAPL, ADP, EL, GRMN, HUM, DLPH, YUM, MDLZ & more CNBC
12:28AM  [$$] Perrigo Says Investigators Searched Its Offices in Generic-Drug Probe The Wall Street Journal
May-02-17 10:57PM  [$$] Perrigo Says Investigators Searched Its Offices in Generic-Drug Probe The Wall Street Journal
09:24PM  Perrigo Offices Searched by U.S. Agents in Drug Price Probe Bloomberg
09:24PM  Perrigo says its offices were searched by DOJ's antitrust division Reuters
09:16PM  Perrigo says its offices were searched by DOJ's antitrust division Reuters
08:59PM  Perrigo Discloses Investigation PR Newswire
Apr-28-17 05:09PM  Perrigo Co. Plc Value Analysis (NYSE:PRGO) : April 28, 2017 Capital Cube
Apr-27-17 08:36AM  Perrigo Co. Plc breached its 50 day moving average in a Bullish Manner : PRGO-US : April 27, 2017 Capital Cube
Apr-25-17 08:46PM  [$$] Perrigo Reaches Agreement With Auditor Over Royalty Accounting The Wall Street Journal
04:41PM  Perrigo falls on restatement just hours after Greenlight's David Einhorn discloses holding CNBC
04:03PM  Perrigo Announces Restatement Of Previously Issued Forms 10-K And 10-Q Financial Statements; Announces Select Preliminary Unaudited First Quarter 2017 Financial Results PR Newswire
01:16PM  David Einhorn's Letter To Greenlight Investors Reveals New Perrigo Position Benzinga
12:44PM  Greenlight adds new longs, closes some shorts, calls GM battle "tough" Reuters
12:17PM  Greenlight returned 1% last quarter vs. S&P 500's 6% gain CNBC Videos
12:35AM  [$$] Perrigo CEO Faces Mounting Pressure as Investors Sound Alarms The Wall Street Journal
Apr-24-17 07:00AM  [$$] Perrigo CEO Faces Mounting Pressure as Investors Sound Alarms The Wall Street Journal
Mar-29-17 04:48PM  PERRIGO CO PLC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhib
Mar-27-17 06:17PM  Hospital stocks buck market drop after Obamacare repeal fails CNBC
06:17PM  Hospital stocks buck market drop after Obamacare repeal fails at CNBC
04:01PM  Perrigo Completes Divestiture Of Tysabri® Royalty Stream For Up To $2.85 Billion PR Newswire
Mar-24-17 07:01PM  Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., FXCM Inc., Innocoll Holdings plc, Momenta Pharmaceuticals, Inc., Omnicom Group Inc., Perrigo Company plc, Santander Consumer USA Holdings Inc. and The Interpublic Group of Companies, Inc. PR Newswire
Mar-23-17 02:31PM  Starboard Value's Jeff Smith Is Top Activist for Naming New Board Members TheStreet.com
02:31PM  Starboard Value's Jeff Smith Is Top Activist for Naming New Board Members
Mar-20-17 01:11PM  Moody's: Perrigo Filing Delay a "Credit Negative" The Wall Street Journal
01:11PM  Moody's: Perrigo Filing Delay a "Credit Negative" at The Wall Street Journal
10:22AM  Perrigo Company plc -- Moody's: Perrigo's delayed 10-K filing is credit negative Moody's
10:22AM  Perrigo Company plc -- Moody's: Perrigo's delayed 10-K filing is credit negative at Moody's
Mar-17-17 04:20PM  PERRIGO CO PLC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tr
Mar-16-17 04:14PM  PERRIGO CO PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligat
04:01PM  Perrigo Provides Update On 2016 Form 10-K Filing PR Newswire
Mar-13-17 04:36PM  Stock market holds its ground as Fed rate decision looms at MarketWatch
Mar-09-17 06:02PM  Perrigo Launches First to Market OTC Equivalent of Rogaine Zacks
05:47PM  RPI Finance Trust -- Moody's confirms RPI Finance Trust at Baa2; negative outlook Moody's
05:47PM  RPI Finance Trust -- Moody's confirms RPI Finance Trust at Baa2; negative outlook at Moody's
Mar-08-17 08:35AM  Perrigo Announces First-To-Market Launch Of The OTC Store Brand Equivalent To Women's Rogaine® Foam PR Newswire
Mar-07-17 04:03PM  Perrigo Provides 2016 Form 10-K Update PR Newswire
12:38PM  Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan
Mar-06-17 11:49AM  Perrigo Company PLC (PRGO) Becomes The Latest Pharma Investigated Over Price Fixing at Insider Monkey
Mar-03-17 10:25AM  Perrigo Joins Firms With Generic Drugs Under U.S. Glare
06:00AM  Mylan's Governance May Be the Root of Its Problems
Mar-02-17 01:15PM  Perrigo Company PLC (PRGO) Drug Gets FDA Approval at Insider Monkey
Mar-01-17 03:49PM  Perrigo Company PLC (PRGO) Sells Rights To Tysabri at Insider Monkey
12:24PM  Five Companies to Benefit from Activist Starboard Values Involvement in 2017 at Insider Monkey
10:36AM  Pawar Law Group Announces Investigation of Securities Claims Against Perrigo Company plc - PRGO Accesswire
10:13AM  EpiPen maker Mylan forecasts strong 2017; shares jump
08:55AM  Perrigo Announces FDA Final Approval For The Generic Version Of Axiron® Topical Solution, 30 mg/1.5 mL PR Newswire
08:44AM  Why Perrigo Company plc Stock Crashed on Tuesday at Motley Fool
Feb-28-17 08:36PM  [$$] Overheard at The Wall Street Journal -11.70%
07:03PM  Perrigo Company plc -- Moody's: Perrigo Company plc - $2.2 Billion Cash Proceeds From Sale of Tysabri Royalty is Credit Positive at Moody's
04:47PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving the Board of Perrigo Company plc Business Wire
04:40PM  Dow snaps win streak as investors await Trump speech at MarketWatch
04:13PM  Kite, Ionis Outplay Med Sector As Perrigo, Tenet, Valeant Dive
02:14PM  Two biotechs taking it on the chin
02:13PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Perrigo Company plc (PRGO) PR Newswire
01:23PM  Perrigo Stock Slump Highlights Dubious Milestone at The Wall Street Journal
12:55PM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Perrigo Company plc PRGO Business Wire
11:13AM  RPI Finance Trust -- Moody's reviews RPI Finance Trust for downgrade at Moody's
10:12AM  Big Money Still Long Valeant
09:43AM  Faber Report: Papa don't preach
09:24AM  Perrigo to Sell Tysabri Royalties; Issues Tepid 2017 View
09:09AM  Morning Movers: Target Tanks, Perrigo Plunges, Tenet Tumbles at Barrons.com
09:04AM  US STOCKS-Wall St to open flat as investors await Trump's speech
08:20AM  PERRIGO CO PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events
07:41AM  Early movers: TGT, VRX, AZO, PCLN, PRGO, ETFC & more at CNBC
07:37AM  US STOCKS-Futures flat ahead of Trump's address to Congress
Feb-27-17 09:40PM  [$$] Perrigo to Sell Multiple-Sclerosis Drug Royalties at The Wall Street Journal
09:22PM  After Starboard Agitation, Perrigo Sells MS Drug Royalties for Up to $2.85B
06:21PM  Perrigo sells Tysabri royalty stream, delays annual report
05:51PM  After0hours buzz: PCLN, FTR, PRGO & more at CNBC
05:20PM  Perrigo CFO resigns, effective immediately
04:50PM  Perrigo Shares Plunge On Plans To Sell MS-Drug Royalty Stream
04:42PM  Perrigo shares down 9% after company reports loss, sells drug royalties at MarketWatch
04:09PM  Perrigo to sell Tysabri's royalty stream to Royalty Pharma-sources
04:05PM  Perrigo Company plc Reports Select Preliminary Unaudited Calendar Year 2016 Financial Results And Initial Calendar Year 2017 Guidance PR Newswire
04:03PM  Perrigo Signs Agreement To Divest Tysabri® Royalty Stream For Up To $2.85 Billion PR Newswire
04:01PM  Perrigo Announces Leadership Changes PR Newswire
07:07AM  Q4 2016 Perrigo Company PLC Earnings Release - After Market Close
Feb-25-17 12:25AM  [$$] Home Depot Looks Fit, UPS Looks Squeezed at Barrons.com
Feb-22-17 10:23AM  Coverage initiated on Perrigo by Canaccord Genuity
02:33AM  Israeli supermarket chain Shufersal Q4 profit up
Perrigo Company plc, together with its subsidiaries, develops, manufactures, markets, and distributes over-the-counter (OTC) consumer goods and pharmaceutical products worldwide. The company operates through Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences, and Other segments. The CHC segment offers OTC products in various categories, including analgesics, cough/cold/allergy/sinus, gastrointestinal, infant nutritional, smoking cessation, animal health, feminine hygiene, diabetes and dermatological care, diagnostic, scar management, and other healthcare products, as well as vitamins, minerals, and dietary supplements (VMS); and contract manufacturing services. It serves retail drug, supermarket, mass merchandise chains, and wholesalers through sales force and industry brokers. The BCH segment provides branded OTC products in the natural health and VMS; cough, cold, flu, and allergy; personal care and derma-therapeutics; lifestyle; pain relief, nasal decongestants, and cold sore management; and anti-parasite areas, as well as offers generic pharmaceutical products. It serves pharmacies, drug, and grocery stores through pharmacy sales force, as well as a network of pharmacists. The Rx segment offers generic and specialty pharmaceutical prescription drugs in various dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, women's health products, oral solid dosage forms, and oral liquid formulations; and ORx products. It serves wholesalers; retail drug, supermarket, and mass merchandise chains; hospitals; and pharmacies. The Specialty Sciences segment offers Tysabri to treat multiple sclerosis. The Other segment offers active pharmaceutical ingredients used by generic and branded pharmaceutical companies. The company was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wesolowski JohnEVP, President RxDec 15Option Exercise82.6132526,848325Dec 19 04:07 PM
Brown Judy LEVP, Business Ops & CFONov 25Sale89.442,097187,55610,007Nov 28 04:29 PM
Parker Geoffrey M.DirectorNov 21Buy88.752,500221,8752,500Nov 21 03:14 PM
KINGMA TODD WExecutive VP, General CounselNov 21Sale88.6875066,51214,560Nov 23 02:30 PM
Brown Judy LEVP, Business Ops & CFOOct 24Sale90.422,092189,15912,104Oct 26 02:44 PM
Farrington ThomasEVP and CIOSep 26Sale96.761,110107,4042,970Sep 28 01:47 PM
Brown Judy LEVP, Business Ops & CFOSep 26Sale96.762,096202,80914,196Sep 28 01:47 PM
KUNKLE GARY K JRDirectorSep 09Option Exercise16.775,81497,50131,501Sep 13 03:01 PM
KUNKLE GARY K JRDirectorSep 09Sale89.955,814522,97425,687Sep 13 03:01 PM
MORRIS HERMAN JRDirectorSep 08Option Exercise16.775,81497,50110,425Sep 09 04:33 PM
MORRIS HERMAN JRDirectorSep 08Sale90.961,07397,5959,352Sep 09 04:33 PM
Brown Judy LEVP, Business Ops & CFOAug 26Sale88.282,095184,94716,292Aug 30 04:38 PM
Weninger PaulEVP, Quality OperationsAug 22Option Exercise91.5218817,2062,296Aug 24 03:54 PM
Brown Judy LEVP, Business Ops & CFOAug 22Option Exercise91.522,877263,30319,717Aug 24 03:53 PM
Farrington ThomasEVP and CIOAug 22Option Exercise91.5269363,4234,299Aug 24 03:53 PM
Quinn GrainneEVP, Chief Medical OfficerAug 22Option Exercise91.522,168198,4153,208Aug 24 03:53 PM
Needham JeffreyEVP, GM Consumer HealthcareAug 22Option Exercise91.521,336122,27111,327Aug 24 03:52 PM
Janish Ronald CraigEVP, Global Op. & Supply ChainAug 22Option Exercise91.5230127,5481,586Aug 24 03:52 PM
HENDRICKSON JOHN TCEOAug 22Option Exercise91.521,536140,5755,401Aug 24 03:52 PM
Kochan SharonEVP, GM InternationalAug 22Option Exercise91.521,336122,27110,088Aug 24 03:51 PM
KINGMA TODD WExecutive VP, General CounselAug 22Option Exercise91.521,536140,57515,796Aug 23 04:58 PM
Brown Judy LEVP, Business Ops & CFOAug 19Option Exercise91.831,692155,37614,121Aug 23 04:58 PM
KINGMA TODD WExecutive VP, General CounselAug 19Option Exercise91.831,692155,37612,012Aug 23 04:58 PM
Kochan SharonEVP, GM InternationalAug 19Option Exercise91.831,01593,2076,898Aug 23 04:57 PM
Needham JeffreyEVP, GM Consumer HealthcareAug 19Option Exercise91.8333831,0397,678Aug 23 04:57 PM
Farrington ThomasEVP and CIOAug 19Option Exercise91.831,692155,3762,886Aug 23 04:57 PM
HENDRICKSON JOHN TCEOAug 19Option Exercise91.831,692155,3761,692Aug 23 04:56 PM